|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Dec―26 |
Syringa reticulata potently inhibits the activity of SARS-CoV-2 3CL protease |
Zhichao Hao, Yuan Liu, Wei Guan, Juan Pan, MengMeng Li, Jiatong Wu, et al. (+3) Yan Liu, Haixue Kuang, Bingyou Yang |
2 |
[GO] |
2023―Nov―02 |
Expression patterns of lncRNA MALAT-1 in SARS-COV-2 infection and its potential effect on disease severity via miR-200c-3p and SIRT1 |
Olfat Shaker, Monica El Amir, Yasmine Abd Elfatah, Heba M. Elwi |
3 |
[GO] |
2023―Jun―02 |
Identification of potential biomarkers to predict organ morbidity in COVID-19: A repository based proteomics perspective |
Sabyasachi Bandyopadhyay, Madhan Vishal Rajan, Punit Kaur, Gururao Hariprasad |
4 |
[GO] |
2023―Apr―25 |
Dried blood spot eluates are suitable for testing of SARS-CoV-2 IgG antibodies targeting Spike protein 1 and Nucleocapsid protein |
Sarah Guttmann, Sebastian Bunte, Simon Eschrig, Nils Janzen, Julia Klemens, Yara Koenemann, et al. (+5) Dieter Münstermann, Thomas Neisse, Tim Niedergassel, Katja Steinhagen, Kristin Maria Meyer-Schlinkmann |
5 |
[GO] |
2023―Mar―07 |
Blood levels of d-amino acids reflect the clinical course of COVID-19 |
Shihoko Kimura-Ohba, Yoshitsugu Takabatake, Atsushi Takahashi, Yoko Tanaka, Shinsuke Sakai, Yoshitaka Isaka, Tomonori Kimura |
6 |
[GO] |
2022―Nov―23 |
In vitro evaluation of the activity of teriflunomide against SARS-CoV-2 and the human coronaviruses 229E and OC43 |
Paul Lang, Svend S. Geertsen, Alex L. Lublin, Michelle C. Potter, Tatiana Gladysheva, Jill S. Gregory, Pascal Rufi |
7 |
[GO] |
2022―Nov―07 |
Comparison of the inactivation capacity of various UV wavelengths on SARS-CoV-2 |
Ryosuke Matsuura, Chieh-Wen Lo, Takayo Ogawa, Masaru Nakagawa, Masami Takei, Yasunobu Matsumoto, et al. (+2) Satoshi Wada, Yoko Aida |
8 |
[GO] |
2022―Sep―22 |
In silico prediction of COVID-19 cytokine storm in lung cancer types |
Surabhi Suchanti, Sonali Awasthi, Gyanendra Singh, Pramod K. Yadav, Abhijeet Singh, Rajeev Mishra |
9 |
[GO] |
2022―Sep―13 |
Simple neutralization test report: Do probiotics contribute to COVID-19 therapy? |
Anna Surgean Veterini, Cita Rosita Sigit Prakoeswa, Damayanti Tinduh, Satuman Satuman |
10 |
[GO] |
2022―Jul―01 |
High-resolution melting analysis to discriminate between the SARS-CoV-2 Omicron variants BA.1 and BA.2 |
Takuro Koshikawa, Hiroshi Miyoshi |
11 |
[GO] |
2022―Apr―21 |
Epigenetic regulation of autophagy in coronavirus disease 2019 (COVID-19) |
Hamid Behrouj, Omid Vakili, Adel Sadeghdoust, Neda Aligolighasemabadi, Parnian Khalili, Mozhdeh Zamani, Pooneh Mokarram |
12 |
[GO] |
2022―Feb―01 |
Common genetic aspects between COVID-19 and sarcoidosis: A network-based approach using gene expression data |
Md. Roman Mogal, Sagarika Adhikary Sompa, Asadullah Junayed, Md. Rashel Mahmod, Md. Zainul Abedin, Md. Asaduzzaman Sikder |
13 |
[GO] |
2022―Jan―31 |
Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations |
Samia E. Omer, Tawasol M. Ibrahim, Omer A. Krar, Amna M. Ali, Alaa A. Makki, Walaa Ibraheem, Abdulrahim A. Alzain |
14 |
[GO] |
2021―Dec―15 |
Iota-carrageenan extracted from red algae is a potent inhibitor of SARS-CoV-2 infection in reconstituted human airway epithelia |
David Bovard, Marco van der Toorn, Walter K. Schlage, Samuel Constant, Kasper Renggli, Manuel C. Peitsch, Julia Hoeng |
15 |
[GO] |
2021―Nov―10 |
Penta-peptide ATN-161 based neutralization mechanism of SARS-CoV-2 spike protein |
Gulam Rabbani, Saeyoung Nate Ahn, Hyunhwa Kwon, Khurshid Ahmad, Inho Choi |
16 |
[GO] |
2021―Jul―19 |
Analysis of SARS-CoV-2 infection associated cell entry proteins ACE2, CD147, PPIA, and PPIB in datasets from non SARS-CoV-2 infected neuroblastoma patients, as potential prognostic and infection biomarkers in neuroblastoma |
Brandon Bergsneider, Elise Bailey, Yusuf Ahmed, Namrata Gogineni, Derek Huntley, Ximena Montano |
17 |
[GO] |
2021―Jul―06 |
Peptide inhibitors against SARS-CoV-2 2′-O-methyltransferase involved in RNA capping: A computational approach |
Mainak Dutta, Eldhose Iype |
18 |
[GO] |
2021―Jun―14 |
Shorter leukocyte telomere length is associated with severity of COVID-19 infection. |
Gabriel Arantes dos Santos, Ruan Pimenta, Nayara I. Viana, Vanessa R. Guimarães, Poliana Romão, Patrícia Candido, et al. (+8) Juliana A. de Camargo, Diná M. Hatanaka, Paula GS. Queiroz, Alexandre Teruya, Katia R.M. Leite, Victor Srougi, Miguel Srougi, Sabrina T. Reis |
19 |
[GO] |
2021―Jun―03 |
In Silico Molecular Docking Analysis for Repurposing Approved Antiviral Drugs against SARS-CoV-2 Main Protease |
Ibrahim Khater, Aaya Nassar |
20 |
[GO] |
2021―May―25 |
Accommodating receptor flexibility and free energy calculation to reduce false positive binders in the discovery of natural products blockers of SARS-COV-2 spike RBD-ACE2 interface |
Marcelina Ogedjo, Isaac Onoka, Mtabazi Sahini, Daniel M. Shadrack |
21 |
[GO] |
2021―May―14 |
Sequence and structural analysis of COVID-19 E and M protein with MERS virus E and M protein-A comparative study |
Ebtisam A. Aldaais, Subha Yegnaswamy, Fatimah Albahrani, Fatima Alsowaiket, Sarah Alramadan |
22 |
[GO] |
2021―Mar―29 |
Repurposing of approved drugs with potential to interact with SARS-CoV-2 receptor |
Tamim Ahsan, Abu Ashfaqur Sajib |
23 |
[GO] |
2021―Feb―27 |
In silico investigation of potential inhibitors to main protease and spike protein of SARS-CoV-2 in propolis |
Azza H. Harisna, Rizky Nurdiansyah, Putri H. Syaifie, Dwi W. Nugroho, Kurniawan E. Saputro, Chandra D. Prakoso, et al. (+4) Nurul T. Rochman, Nurwenda N. Maulana, Alfian Noviyanto, Etik Mardliyati |
24 |
[GO] |
2021―Feb―06 |
SUMO pathway, blood coagulation and oxidative stress in SARS-CoV-2 infection |
Iman Hassan Ibrahim, Doha El-Sayed El-lakwa |
25 |
[GO] |
2021―Jan―27 |
Variations in Orf3a protein of SARS-CoV-2 alter its structure and function |
Gajendra Kumar Azad, Parimal Kumar Khan |
26 |
[GO] |
2020―Dec―29 |
Mutational sensitivity of D614G in spike protein of SARS-CoV-2 in Jordan |
Walid Al-Zyoud, Hazem Haddad |
27 |
[GO] |
2020―Dec―12 |
Analysis of non-structural proteins, NSPs of SARS-CoV-2 as targets for computational drug designing |
Resal Raj |
28 |
[GO] |
2020―Nov―05 |
SARS-CoV-2 cell receptor gene ACE2 -mediated immunomodulation in breast cancer subtypes |
Vikas Kumar Bhari, Durgesh Kumar, Surendra Kumar, Rajeev Mishra |
29 |
[GO] |
2020―Oct―10 |
Identification of novel mutations in the methyltransferase complex (Nsp10-Nsp16) of SARS-CoV-2 |
Gajendra Kumar Azad |
30 |
[GO] |
2020―Aug―20 |
ACE2 coding variants in different populations and their potential impact on SARS-CoV-2 binding affinity |
Fedaa Ali, Menattallah Elserafy, Mohamed H. Alkordi, Muhamed Amin |